BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14585970)

  • 1. A human globin enhancer causes both discrete and widespread alterations in chromatin structure.
    Kim A; Dean A
    Mol Cell Biol; 2003 Nov; 23(22):8099-109. PubMed ID: 14585970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2.
    Gui CY; Dean A
    Mol Cell Biol; 2001 Feb; 21(4):1155-63. PubMed ID: 11158302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
    Gong QH; McDowell JC; Dean A
    Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleosome and transcription activator antagonism at human beta-globin locus control region DNase I hypersensitive sites.
    Kim A; Song SH; Brand M; Dean A
    Nucleic Acids Res; 2007; 35(17):5831-8. PubMed ID: 17720709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer blocking by chicken beta-globin 5'-HS4: role of enhancer strength and insulator nucleosome depletion.
    Zhao H; Kim A; Song SH; Dean A
    J Biol Chem; 2006 Oct; 281(41):30573-80. PubMed ID: 16877759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.
    McDowell JC; Dean A
    Mol Cell Biol; 1999 Nov; 19(11):7600-9. PubMed ID: 10523648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transcriptional activator GATA-1 at human beta-globin HS2.
    Cho Y; Song SH; Lee JJ; Choi N; Kim CG; Dean A; Kim A
    Nucleic Acids Res; 2008 Aug; 36(14):4521-8. PubMed ID: 18586828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-globin intergenic transcription and histone acetylation dependent on an enhancer.
    Kim A; Zhao H; Ifrim I; Dean A
    Mol Cell Biol; 2007 Apr; 27(8):2980-6. PubMed ID: 17283048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature of the accessible chromatin at a glucocorticoid-responsive enhancer.
    Flavin M; Cappabianca L; Kress C; Thomassin H; Grange T
    Mol Cell Biol; 2004 Sep; 24(18):7891-901. PubMed ID: 15340052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators.
    Pikaart MJ; Recillas-Targa F; Felsenfeld G
    Genes Dev; 1998 Sep; 12(18):2852-62. PubMed ID: 9744862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene.
    Zhao H; Dean A
    Nucleic Acids Res; 2004; 32(16):4903-19. PubMed ID: 15371553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental stage differences in chromatin subdomains of the beta-globin locus.
    Kim A; Dean A
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7028-33. PubMed ID: 15105444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetylation contributes to chromatin looping between the locus control region and globin gene by influencing hypersensitive site formation.
    Kim YW; Kim A
    Biochim Biophys Acta; 2013 Sep; 1829(9):963-9. PubMed ID: 23607989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain.
    Im H; Grass JA; Christensen HM; Perkins A; Bresnick EH
    Biochemistry; 2002 Dec; 41(51):15152-60. PubMed ID: 12484752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A WW domain-binding motif within the activation domain of the hematopoietic transcription factor NF-E2 is essential for establishment of a tissue-specific histone modification pattern.
    Kiekhaefer CM; Boyer ME; Johnson KD; Bresnick EH
    J Biol Chem; 2004 Feb; 279(9):7456-61. PubMed ID: 14597626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
    Kim J; Kang J; Kim YW; Kim A
    FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer requirement for histone methylation linked with gene activation.
    Rentoft M; Kim K; Cho Y; Lee CH; Kim A
    FEBS J; 2008 Dec; 275(23):5994-6001. PubMed ID: 19021773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer activity of HS2 of the human beta-LCR is modulated by distance from the key nucleosome.
    Onishi Y; Kiyama R
    Nucleic Acids Res; 2001 Aug; 29(16):3448-57. PubMed ID: 11504883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.